Diagnostic Testing During a Pandemic

Published on: 

A digital health company’s quest to improve the delivery and scaling of lab testing

Pouria Sanae, CEO of ixlayer, a technology company, explains the obstacles surrounding the distribution of remote lab tests pre-, during and post-pandemic, the shift to at-home Covid screenings, the logistical challenges in collaborating with different US regions, and the concept of the “pre-patient” model for preventative care.

The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.